Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Latest in precision cancer medicine

Prof Richard Schilsky - Chief Medical Officer, ASCO

Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )

Advances in first line treatment options for MCL patients

Professor Steven Le Gouill and Professor Simon Rule

Advances in first line treatment options for MCL patients ( Professor Steven Le Gouill and Professor Simon Rule )

The latest in CLL from EHA 2016

Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam

The latest in CLL from EHA 2016 ( Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam )

An overview of MCL from EHA 2016

Professor Simon Rule and Professor Steven Le Gouill

An overview of MCL from EHA 2016 ( Professor Simon Rule and Professor Steven Le Gouill )

ASCO 2016: Current treatment approaches for advanced prostate cancer

Prof Przemyslaw Twardowski and Prof Gordon McVie

ASCO 2016: Current treatment approaches for advanced prostate cancer ( Prof Przemyslaw Twardowski and Prof Gordon McVie )

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?

Prof Charles Ryan and Prof Nick James

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer? ( Prof Charles Ryan and Prof Nick James )

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA

Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK

Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )

ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational...

Prof Nick James and Prof Charles Ryan

ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational biopsy ( Prof Nick James and Prof Charles Ryan )

Impact of precision medicine in refractory malignancies

Prof Maria Schwaederle - University of California, San Diego, USA

$Impact of precision medicine in refractory malignancies ( Prof Maria Schwaederle - University of California, San Diego, USA )$

Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung...

Dr Madhusmita Behera - Emory University, Atlanta, USA

Photon vs proton beam therapy: modality in radiotherapy for non-small cell lung cancer ( Dr Madhusmita Behera - Emory University, Atlanta, USA )

Phase I study of sapacitabine and seliciclib in patients with advanced solid...

Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA

Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours ( Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA )

More from ecancer